What's New

Last Posted: Jan 31, 2023

• Extensive SARS-CoV-2 testing reveals BA.1/BA.2 asymptomatic rates and underreporting in school children
  MM Martignoni et al, MEDRXIV, January 30, 2023
• High number of SARS-CoV-2 persistent infections uncovered through genetic analysis of samples from a large community-based surveillance study
  M Ghafari et al, MEDRXIV, January 30, 2023
• Machine learning models for predicting severe COVID-19 outcomes in hospitals
  P Wendland et al, MEDRXIV, January 30, 2023
• Therapeutic potential of IL6R blockade for the treatment of sepsis and sepsis-related death: A mendelian randomisation study.
  Fergus W Hamilton et al. PLoS medicine 2023 1 (1) e1004174
• A large-scale machine learning study of sociodemographic factors contributing to COVID-19 severity
  M Tumbas et al, MEDRXIV, January 29, 2023
• Genomic surveillance of SARS-CoV-2 in COVID-19 vaccinated healthcare workers in Lebanon.
  Habib AlKalamouni et al. BMC medical genomics 2023 1 (1) 14
• Omicron BA.1/BA.2 infections in triple-vaccinated individuals enhance a diverse repertoire of mucosal and blood immune responses
  H Hornsby et al, MEDRXIV, January 29, 2023
• Agent-based modeling and phylogenetic analysis suggests that COVID-19 will remain a low-severity albeit highly transmissible disease
  JCT Roy et al, MEDRXIV, January 28, 2023
• Association between APOL1 risk variants and progression from infection to sepsis
  L Jiang et al, MEDRXIV, January 28, 2023
• Spatiotemporal transmission of SARS-CoV-2 lineages during 2020-2021 in Pernambuco - Brazil
  LC Machado et al, MEDRXIV, January 28, 2023